Private Equity

With a world-class project team, Critical Metals Corp. is accelerating its massive Tanbreez project to challenge China's grip on critical minerals.

With national security clearance secured, silicon carbide leader Wolfspeed completes its restructuring, forging a powerful alliance with Japan's Renesas.

Ruxolitinib cream's landmark approval in China marks a new era for vitiligo treatment, impacting patients, markets, and regulatory policy.

With a 98.2% jet card renewal rate and major fleet expansion, the private operator's referral-driven success offers a lesson in high-end service.

As SmartStop sets its Q4 earnings date, investors watch to see if its aggressive expansion and acquisition spree can translate into sustained profitability.

Facing a cash crunch after a major clinical trial setback, the cancer vaccine developer is exploring a sale or merger, putting its pipeline at risk.

A landmark partnership between TotalEnergies and Galp is set to unlock billions of barrels of oil, positioning Namibia as a new global energy powerhouse.

A federal grant to 5N Plus aims to boost domestic germanium production, a key material for night vision and satellites, directly challenging foreign supply chains.

Nuwellis appoints Carisa Schultz as CFO, a strategic move to leverage her public company expertise as it navigates growth and financial challenges.

A $10M investment from pharma giant Dr. Reddy’s validates Coya Therapeutics' novel ALS drug, funding the path to commercial-scale manufacturing.

Bonaccord Capital Partners' new award highlights its success in the booming GP stakes market and validates parent company P10's strategic middle-market focus.

Sundream's acquisition of Atlantic Plumbing Services signals a major consolidation trend in home services, blending local legacy with regional platform growth.

With stronger Phase 2 data for its ATH434 drug and a healthy cash reserve, Alterity Therapeutics is preparing for a pivotal trial and seeking partners.

BNY's long-term deal with Williams F1 signals a major strategic play ahead of the sport's 2026 rule reset. Is this the fuel for a historic comeback?

Nexstar Media Group maintains its robust dividend, signaling confidence while channeling cash towards its massive $6.2 billion acquisition of TEGNA.

The market for drugs like Ozempic and Wegovy is set to explode, fueled by new oral pills, expanded uses for heart and liver disease, and fierce competition.

Swedish developer Minesto secures funding to build tidal energy farms in Taiwan, a key step in the island's ambitious renewable energy transition.

HKPC's elite internship lures global talent from MIT to the Belt and Road, positioning Hong Kong as a vital I&T bridge between China and the world.

The global fitness giant is exploring a Wall Street listing and launching a DNA-based longevity program, signaling a major push for market leadership.

NB Private Equity Partners caps 2025 with strong realizations, aggressive share buybacks, and new investments, showcasing a dynamic private equity strategy.